Joanne Walker
Publishing Head and Managing Director, PharmaPlatforms at Future Oncology
Co-founder & Publishing Director, Becaris Publishing (@_Becaris). Focus on all things real-world evidence, HEOR & #PlainLanguageSummaries. Views are my own.
Articles
-
Oct 7, 2024 |
evidencebaseonline.com | Joanne Walker
Explore the latest advancements in real-world data (RWD), real-world evidence (RWE) and health technology assessment (HTA) as featured on The Evidence Base during September 2024. Proscia introduces comprehensive real-world data offering for precision medicineProscia’s new RWD solution provides over 10 million pathology images integrated with clinical and genomic data to advance precision medicine.
-
Oct 3, 2024 |
evidencebaseonline.com | Joanne Walker
The draft guidance outlines how the US Centers for Medicare & Medicaid Services intends to implement the Medicare Drug Price Negotiation Program for the second round of drugs subject to price controls in 2027. Following publication of the draft guidance in May 2024, the US Centers for Medicare & Medicaid Services (CMS) has finalized guidance for the next phase of the Medicare Drug Price Negotiation Program (the ‘Negotiation Program’).
-
Oct 3, 2024 |
evidencebaseonline.com | Katie McCool |Joanne Walker
PrecisionLife and Metrodora Institute’s MetX study uses real-world data to identify the genetic associations in ME/CFS and long COVID, aiming to advance personalized treatment options for these conditions. PrecisionLife, a clinical-stage precision medicine company, and the Metrodora Institute, a leading healthcare center specializing in multisystem disorders, have announced the first results from their collaborative MetX study.
-
Oct 2, 2024 |
evidencebaseonline.com | Joanne Walker
Next month, ISPOR Europe 2024 will bring together leading professionals in health economics and outcomes research (HEOR) and real-world evidence (RWE) in Barcelona, Spain. From November 17 to 20, the conference will feature a comprehensive program centered around the theme “Generating Evidence Toward Health and Well-Being.” In this preview, we highlight the key plenary sessions scheduled across the event’s main three days. The Evidence-Price Conundrum: What Is the Way Forward for Patient Access?
-
Oct 1, 2024 |
evidencebaseonline.com | Joanne Walker
The fourth implementing act has been released, with the European Commission seeking feedback on the proposed rules joint scientific consultations. With the Regulation (EU) 2021/2282EN on health technology assessment (HTAR) coming into effect January 2025, the European Commission is ramping up its advice to stakeholders looking to participate in the process.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 546
- Tweets
- 1K
- DMs Open
- No
RT @TheEviBase: New Spotlight from @TheEviBase on Health Technology Assessment; featuring, among others, @cytel, @lumanity, @aetioninc, @ic…
RT @TheEviBase: In her latest monthly column, @Laura_Dormer shares some of her Editor's highlights from the August issue of @Journal_CER, n…
RT @Journal_CER: Our latest #PlainLanguageSummary summarizes the results of a study looking at the long-term treatment of uterine fibroids.…
